INS and Hepatic steatosis: Because food intake of palmitoleate-supplemented mice did not differ from that of control mice, the observed insulin-sensitizing effect, as well as alterations of hepatic steatosis and liver inflammatory response upon palmitoleate supplementation (see below), is not due to a decrease in energy intake.